Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

E. coli Lipopolysaccharides·Î À¯µµµÈ »ç¶÷ È£Áß±¸¿¡¼­ CD14, Toll-Like receptors, cytoskeletal inhibitors ±×¸®°í NF-¥êB inhibitor°¡ MMP-8 ºÐºñ¿¡ ¹ÌÄ¡´Â ¿µÇâ

Effect of CD14, Toll-Like receptors, cytoskeletal inhibitors and NF-¥êB inhibitor on MMP-8 release from human neutrophils induced by E. coli Lipopolysaccharides

´ëÇÑÄ¡ÁÖ°úÇÐȸÁö 2005³â 35±Ç 2È£ p.427 ~ 436
¼Ò¼Ó »ó¼¼Á¤º¸
¾ç½Â¹Î ±èÅÂÀÏ/¼³¾çÁ¶/À̿빫/±¸¿µ/Á¤Á¾Æò/ÇѼöºÎ/·ùÀÎö

Abstract


Objective: MMP-8 is a neutrophil enzyme and its level increases in some inflammatory
diseases, including periodontal disease. We knew that the lipopolysaccharide of E.coli(E-LPS)
induced MMP-8 release from human neutrophils. E-LPS is known to induce the production
and release of inflammatory cytokines through CD14, Toll-like receptor(TLR). In the present
study, we investigated whether MMP-8 release by E-LPS is induced via CD14-TLR
pathway and the cellular mechanism of MMP-8 release in human neutrophils.
Material and methods: Human neutrophils were isolated from the peripheral blood of
healthy donors and pre-incubated in medium containing antibodies against CD14, anti-TLR2
and anti-TLR4 or several inhibitors of microtubules and microfilaments and then incubated
with E-LPS. The cells were treated TPCK and E-LPS simultaneously. The MMP-8amount
in the culture medium was determined using ELISA.
Results: E-LPS increased MMP-8release from neutrophils and its induction was inhibited
by anti- CD14 and anti-TLR4 but not by anti-TLR2 antibodies. The inhibitors of microtubule and microfilament polymerization significantly decreased E-LPS-induced MMP8release. TPCK inhibited E-LPS-induced MMP-8 release.
Conclusion: These results suggest that MMP-8 release is induced by E-LPS via the
CD14-TLR4 signal pathway in human neutrophils and may be depedent on microtubule and
microfilament systems and NF-¥êB pathway.

Å°¿öµå

Human Neutrophil;CD14;TLRs;Cytoskeletal Inhibitors;NF-B inhibitor;MMP-8

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI